Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and genetic differences between pustular psoriasis subtypes.
Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, Cooper HL, Irvine AD, Oon HH, Kingo K, Köks S, Mrowietz U, Puig L, Reynolds N, Tan ES, Tanew A, Torz K, Trattner H, Valentine M, Wahie S, Warren RB, Wright A, Bata-Csörgő Z, Szell M, Griffiths CEM, Burden AD, Choon SE, Smith CH, Barker JN, Navarini AA, Capon F. Twelves S, et al. Among authors: tanew a. J Allergy Clin Immunol. 2019 Mar;143(3):1021-1026. doi: 10.1016/j.jaci.2018.06.038. Epub 2018 Jul 21. J Allergy Clin Immunol. 2019. PMID: 30036598 Free PMC article.
Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study.
Tzaneva S, Geroldinger A, Trattner H, Tanew A. Tzaneva S, et al. Among authors: tanew a. Br J Dermatol. 2018 Mar;178(3):682-688. doi: 10.1111/bjd.16106. Epub 2018 Jan 31. Br J Dermatol. 2018. PMID: 29114862 Clinical Trial.
Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis.
Benzian-Olsson N, Dand N, Chaloner C, Bata-Csorgo Z, Borroni R, Burden AD, Cooper HL, Cornelius V, Cro S, Dasandi T, Griffiths CEM, Kingo K, Koks S, Lachmann H, McAteer H, Meynell F, Mrowietz U, Parslew R, Patel P, Pink AE, Reynolds NJ, Tanew A, Torz K, Trattner H, Wahie S, Warren RB, Wright A, Barker JN, Navarini AA, Smith CH, Capon F; ERASPEN consortium and the APRICOT and PLUM study team. Benzian-Olsson N, et al. Among authors: tanew a. JAMA Dermatol. 2020 Nov 1;156(11):1216-1222. doi: 10.1001/jamadermatol.2020.3275. JAMA Dermatol. 2020. PMID: 32936291 Free PMC article.
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis.
Graier T, Weger W, Sator PG, Salmhofer W, Gruber B, Jonak C, Kölli C, Schütz-Bergmayr M, Vujic I, Ratzinger G, Häring N, Painsi C, Prillinger K, Mlynek A, Skvara H, Trattner H, Tanew A, Lichem R, Ellersdorfer C, Legat F, Gruber-Wackernagel A, Hofer A, Schmiedberger E, Hoetzenecker W, Müllegger R, Saxinger W, Quehenberger F, Wolf P. Graier T, et al. Among authors: tanew a. JAAD Int. 2020 Dec 26;2:62-75. doi: 10.1016/j.jdin.2020.10.012. eCollection 2021 Mar. JAAD Int. 2020. PMID: 34409355 Free PMC article.
Photosensitizing compounds in the treatment of psoriasis.
Hönigsmann H, Tanew A, Brücke J, Ortel B. Hönigsmann H, et al. Among authors: tanew a. Ciba Found Symp. 1989;146:159-67; discussion 167-70. doi: 10.1002/9780470513842.ch11. Ciba Found Symp. 1989. PMID: 2697531 Review.
119 results